A child from Monzón overcomes epileptic seizures of up to eight hours with a novel intervention
9 April 2021
The European Court of Human Rights endorses mandatory childhood vaccination
9 April 2021
Headaches, blurred vision, vomiting or difficulty breathing are some of the symptoms that can warn of thrombosis and these symptoms can appear up to 14 days after inoculation with the Astrazeneca vaccine.
Headaches or headaches, blurred vision, vomiting or difficulty breathing are some of the symptoms that can alert health professionals to a possible cerebral venous sinus thrombosis, a circumstance that has led to limiting vaccination with Astrazeneca to people of between 60 and 65 years old.
These are some of the symptoms that would warn of the development of thrombosis in people who have been vaccinated with this drug, according to the European Medicines Agency and the Federation of Spanish Scientific Medical Associations, and that can appear up to 14 days after vaccination.
However, the communities continue to administer this vaccine this Thursday to people between 60 and 65, like Castilla y León, which this Wednesday stopped immunization with this drug.
Cerebral venous sinus thrombosis is a rare cerebrovascular disease that affects young women more and, treated in time, has a much more favorable prognosis than other similar pathologies.
These cases represent less than 0,5% of the total cases of cerebrovascular diseases that occur in Spain, and their incidence is between 1 and 1,3 cases per 100.000 inhabitants per year, explain the neurologists, as explained by the Spanish Society of Neurology.
These are the symptoms that can warn of thrombosis, according to the sources cited:
- Respiratory distress
- Chest pain
- Swelling in the leg
- Persistent abdominal pain
- Headaches or headaches
- Blurred vision
- Spots of blood under the skin beyond the injection site
- Vomiting
- epileptic seizures
- Behavioral alteration
- Loss of strength or sensation
- Low level of consciousness
